MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pintor, J.
Right arrow Articles by Miras-Portugal, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pintor, J.
Right arrow Articles by Miras-Portugal, M. T.

0026-895X/97/020277-08$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 51:277-284 (1997).

Diinosine Polyphosphates, a Group of Dinucleotides with Antagonistic Effects on Diadenosine Polyphosphate Receptor

Jesús Pintor, Javier Gualix, and M. Teresa Miras-Portugal

Departamento de Bioquimica (J.G., M.T.M.-P.) and E. U. Optica (J.P.), Facultad de Veterinaria, Universidad Complutense de Madrid, 28040 Madrid, Spain

A new family of dinucleotide derivatives, diinosine polyphosphates, has been synthesized through the use of the enzyme 5' adenylic acid deaminase from Aspergillus sp., starting from the corresponding diadenosine polyphosphates. Functional studies were performed on rat brain synaptic terminals in which a dinucleotide receptor has been described that is specific for adenine dinucleotides. The results demonstrated that diinosine polyphosphates did not behave as agonists on the diadenosine polyphosphate receptor (also know as P4 purinoceptor), but they were very efficient as antagonists in abolishing the Ca2+ responses elicited by diadenosine pentaphosphate. The IC50 values for diinosine triphosphate, diinosine tetraphosphate, and diinosine pentaphosphate were 4.90 ± 0.10 µM, 8.33 ± 0.22 µM, and 4.23 ± 0.12 nM, respectively. The diinosine polyphosphates also antagonized the ATP receptors present in synaptic terminals, showing IC50 values of 100.08 ± 5.72 µM for diinosine triphosphate, 29.51 ± 1.40 µM for diinosine tetraphosphate and 27.75 ± 1.65 µM for diinosine pentaphosphate. The antagonistic ability of these diinosine nucleotides was studied in comparison with other P1 and P2 purinoceptor antagonists, such as suramin, pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid, and 8-cyclopentyl-1,3-dipropylxanthine. These purinergic antagonists did not inhibit the response of the P4 purinoceptor; only the diinosine polyphosphates were able to act as antagonists on the dinucleotide receptor. Suramin and pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid attenuated the responses elicited by ATP, as did the diinosine polyphosphate compounds. The most antagonistic diinosine polyphosphate for the dinucleotide and ATP receptors was diinosine pentaphosphate, which was 6000 times more selective for the P4 purinoceptor than it was for the ATP receptor.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. Diaz-Hernandez, J. Sanchez-Nogueiro, J. Pintor, and M. T. Miras-Portugal
Interaction between Dinucleotide and Nicotinic Receptors in Individual Cholinergic Terminals
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 954 - 967.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Gomez-Villafuertes, J. Pintor, J. Gualix, and M. T. Miras-Portugal
GABA Modulates Presynaptic Signalling Mediated by Dinucleotides on Rat Synaptic Terminals
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1148 - 1157.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Diaz-Hernandez, M. F. Pereira, J. Pintor, R. A. Cunha, J. A. Ribeiro, and M. T. Miras-Portugal
Modulation of the Rat Hippocampal Dinucleotide Receptor by Adenosine Receptor Activation
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 441 - 450.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. A. Flores, B. M. Stavrou, and D. J. Sheridan
The effects of diadenosine polyphosphates on the cardiovascular system
Cardiovasc Res, April 1, 1999; 42(1): 15 - 26.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics